These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 680117)

  • 1. [Biopharmaceutical characteristics of sodium mefenaminate suppositories].
    Slobodianiuk MM
    Farm Zh; 1978; (3):88-9. PubMed ID: 680117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optimization of the technology and a study of rectal drug forms. II. The technology and biopharmaceutical study of molded suppositories of sodium mephenaminate].
    Slobodianiuk NN; Golovkin VA; Groshovyĭ TA
    Farm Zh; 1978; (2):64-6. PubMed ID: 658345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. II. Analysis of suppositories prepared on lipophilic bases].
    Kosior A
    Acta Pol Pharm; 1984; 41(5):565-9. PubMed ID: 6532137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
    Kosior A
    Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biopharmaceutical evaluation of the rectal application of mefenamic acid. I. Study of the suppositories prepared on hydrophilic bases].
    Kosiar A
    Acta Pol Pharm; 1983; 40(1):105-9. PubMed ID: 6880815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Technology optimization and a study of rectal drug forms. I. The use of experimental design in the technology of pediatric molded suppositories made of sodium mefenaminate].
    Golovkin VA; Groshovyĭ TA; Slobodianiuk NN
    Farm Zh; 1976; (4):51-4. PubMed ID: 1001421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories].
    Golovkin VA; Lukash EP; Fadeicheva AG; Groshovyĭ TA; Mokhort NA
    Farmatsiia; 1978; 27(4):16-9. PubMed ID: 689174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biopharmaceutical characteristics of pediatric pressed paracetamol suppositories].
    Lukash OP; Golovkin VO; Slivko SF; Ribalka NG
    Farm Zh; 1975; (2):81-3. PubMed ID: 1140369
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biopharmaceutical testing of suppositories containing salicyclic acid derivatives. I. In vitro membrane diffusion methods].
    Kapás M; Kedvessy G; Regdon G; Minker E; Magyarlaki A
    Acta Pharm Hung; 1981 Jul; 51(4):161-7. PubMed ID: 7293784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biopharmaceutical characteristics of sodium oxybutyrate].
    Lebedenko VIa; Shubenkin NG; Azhgikhin IS; Knizhnik AZ; Senov PL
    Farmatsiia; 1972; 21(2):22-5. PubMed ID: 5018333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anal suppositories containing antiphlogistic and analgesic substances. III. Stability of anal suppositories containing mefenamic acid prepared on selected hydrophobic bases].
    Kosior A
    Ann Univ Mariae Curie Sklodowska Med; 1985; 40():203-8. PubMed ID: 3917082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. IV. Biological availability of mefenamic acid on the base of polyoxyethylene glycol with the addition of polysorbates].
    Kosior A
    Acta Pol Pharm; 1987; 44(1):91-5. PubMed ID: 3673627
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biopharmaceutical study of sulfadimidine-containing suppositories].
    Regdon G; Magyarlaki A; Kedvessy G; Minker E; Regdon E
    Pharmazie; 1978 Jan; 33(1):67-9. PubMed ID: 674279
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopharmaceutical study of insulin suppositories.
    Mesiha MS; Lobel S; Salo DP; Khaleeva LD; Zekova NY
    Pharmazie; 1981; 36(1):29-32. PubMed ID: 7012849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biopharmaceutical study of vaginal suppositories made of estradiol dipropionate].
    Marynina TF; Selichenko AH; Kuz'menko ES
    Farm Zh; 1980; (1):41-4. PubMed ID: 7371808
    [No Abstract]   [Full Text] [Related]  

  • 16. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biopharmaceutical study of corglycon suppositories].
    Khapugina LL
    Farmatsiia; 1978; 27(5):30-2. PubMed ID: 700180
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biopharmaceutical aspects of administration of some analgesics and spasmolytics in the form of rectal suppositories].
    Tentsova EM; Buzovskiĭ AN; Azhgikhin IS; Tiurin NA; Kolesov DV
    Farmatsiia; 1970; 19(6):21-6. PubMed ID: 5510372
    [No Abstract]   [Full Text] [Related]  

  • 19. Formulation of diazepam containing rectal suppositories and experiences of their biopharmaceutical study.
    Regdon G; Bácskay I; Kata M; Selmeczi B; Szikszay M; Sánta A; Bálint GS
    Pharmazie; 1994 May; 49(5):346-9. PubMed ID: 8016180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biopharmaceutical studies on vaginal suppositories containing antibiotics and antimycotics].
    Török J; Sallay J; Altmayer P
    Pharmazie; 1982 Aug; 37(8):600-2. PubMed ID: 7146069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.